Kevin P. Kerns

Array ( [id] => 5360470 [patent_doc_number] => 20090035264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'STORAGE STABLE POWDER COMPOSITIONS OF INTERLEUKIN-4 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/246476 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14866 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035264.pdf [firstpage_image] =>[orig_patent_app_number] => 12246476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618970 [patent_doc_number] => 07998686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Method for determining sepsis using pro-BNP' [patent_app_type] => utility [patent_app_number] => 12/240485 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5315 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998686.pdf [firstpage_image] =>[orig_patent_app_number] => 12240485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403478 [patent_doc_number] => 20090238792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'SUPPRESSION OF POSTOPERATIVE ILEUS' [patent_app_type] => utility [patent_app_number] => 12/240517 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 17743 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238792.pdf [firstpage_image] =>[orig_patent_app_number] => 12240517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 103133 [patent_doc_number] => 07723492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Method for the detection of sepsis using procalcitonin-3-116' [patent_app_type] => utility [patent_app_number] => 12/240500 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5314 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723492.pdf [firstpage_image] =>[orig_patent_app_number] => 12240500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331493 [patent_doc_number] => 20090111970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'CANINE AND FELINE IMMUNOREGULATORY PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/234136 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15216 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111970.pdf [firstpage_image] =>[orig_patent_app_number] => 12234136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10601283 [patent_doc_number] => 09321837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Method for the treatment of glomerulonephritis by administering an IL-6 antibody' [patent_app_type] => utility [patent_app_number] => 12/676297 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12483 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 168848 [patent_doc_number] => 07667003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Antibody directed to human mist (mast cell immunoreceptor signal transducer)' [patent_app_type] => utility [patent_app_number] => 12/231623 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 37745 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667003.pdf [firstpage_image] =>[orig_patent_app_number] => 12231623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302179 [patent_doc_number] => 20100068173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Recombinant Human Albumin-Interleukin-11 Fusion Protein With Long-Lasting Biological Effects' [patent_app_type] => utility [patent_app_number] => 12/203116 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16274 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068173.pdf [firstpage_image] =>[orig_patent_app_number] => 12203116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266396 [patent_doc_number] => 20100298214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'TREATMENT OF AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/672436 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 44197 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298214.pdf [firstpage_image] =>[orig_patent_app_number] => 12672436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8771946 [patent_doc_number] => 08425897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Compositions containing LAG-3 and cells that secrete GM-CSF and methods of use' [patent_app_type] => utility [patent_app_number] => 12/201905 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 24 [patent_no_of_words] => 18014 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12201905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 246751 [patent_doc_number] => 07585502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Mammalian CX3C chemokine antibodies' [patent_app_type] => utility [patent_app_number] => 12/198626 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23143 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585502.pdf [firstpage_image] =>[orig_patent_app_number] => 12198626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265501 [patent_doc_number] => 20090118186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Use of TRAIL Polypeptides to Treat Cancer' [patent_app_type] => utility [patent_app_number] => 12/195564 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23827 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118186.pdf [firstpage_image] =>[orig_patent_app_number] => 12195564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634672 [patent_doc_number] => 08013124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Antibodies to human zcytor17 ligand' [patent_app_type] => utility [patent_app_number] => 12/193665 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 80446 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/013/08013124.pdf [firstpage_image] =>[orig_patent_app_number] => 12193665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792188 [patent_doc_number] => 20080293162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Methods and compositions for diagnosing neoplastic disease' [patent_app_type] => utility [patent_app_number] => 12/189051 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14272 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293162.pdf [firstpage_image] =>[orig_patent_app_number] => 12189051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330182 [patent_doc_number] => 20090110659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Human chemotactic cytokine' [patent_app_type] => utility [patent_app_number] => 12/221458 [patent_app_country] => US [patent_app_date] => 2008-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25687 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20090110659.pdf [firstpage_image] =>[orig_patent_app_number] => 12221458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452652 [patent_doc_number] => 20090068689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Molecular phenotyping of severe asthma' [patent_app_type] => utility [patent_app_number] => 12/220263 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8887 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068689.pdf [firstpage_image] =>[orig_patent_app_number] => 12220263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571183 [patent_doc_number] => 08337825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Glycosaminoglycan-antagonising MCP-1 mutants' [patent_app_type] => utility [patent_app_number] => 12/670378 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 6280 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12670378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131978 [patent_doc_number] => 07695717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Method of treating an IL-1 related inflammatory disease or condition' [patent_app_type] => utility [patent_app_number] => 12/218997 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 22 [patent_no_of_words] => 36162 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/695/07695717.pdf [firstpage_image] =>[orig_patent_app_number] => 12218997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599705 [patent_doc_number] => 07582742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Method of treating or preventing an IL-1 related disease or condition' [patent_app_type] => utility [patent_app_number] => 12/218914 [patent_app_country] => US [patent_app_date] => 2008-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 22 [patent_no_of_words] => 36167 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582742.pdf [firstpage_image] =>[orig_patent_app_number] => 12218914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290901 [patent_doc_number] => 20090023631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery' [patent_app_type] => utility [patent_app_number] => 12/174769 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5037 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023631.pdf [firstpage_image] =>[orig_patent_app_number] => 12174769 [rel_patent_id] =>[rel_patent_doc_number] =>)